Atrial Septal Defect (ASD) is a congenital heart anomaly characterized by an abnormal opening between the atria, the upper chambers of the heart. This opening, known as the septum, fails to close properly during fetal development, resulting in a passage between the left and right atria. The size and location of the defect influence the impact on heart function. Small ASDs may be asymptomatic and go unnoticed, while larger defects can pose a risk of complications, such as arrhythmias, pulmonary hypertension, or stroke. Diagnosis involves a comprehensive evaluation, including physical examinations, imaging tests, and echocardiograms. Treatment approaches vary, ranging from monitoring for small, asymptomatic defects to surgical repair or catheter-based procedures for larger or symptomatic cases. Ongoing advancements in medical technology and treatment strategies contribute to improved outcomes for individuals with ASD, emphasizing the importance of regular follow-up care to manage and monitor heart health effectively.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation